Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.62EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.62EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-9164.47South Korea
HK.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-17621Germany
HK.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-11629.5South Korea
JN.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22146.3Germany
JN.1.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-9164.47South Korea
EK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-17621Germany
EK.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EK.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EK.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EK.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.6.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.6.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.6.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.6.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.6.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used